G
Monte Rosa Therapeutics
GLUE
4.38000
USD
-0.14
(-3.10%)
مغلق
حجم التداول
26,766
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
521,669,004
الأخبار
العنوان: Monte Rosa Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their most advanced product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.